Company Description

Gatehouse Bio (formerly known as SRnalytics) is a biotechnology company specializing in developing novel therapeutics for autoimmune diseases. The company's proprietary platform leverages single-cell genomics and machine learning to identify and target key immune cell populations involved in autoimmune responses. Gatehouse Bio's approach aims to deliver personalized treatments that modulate the immune system with high precision, potentially offering more effective and safer alternatives to traditional autoimmune therapies.